Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liangyin Wei
Observed names:
L Wei,
Wei, Liangyin
Institutions:
Nanjing University of Chinese Medicine,
Jiangsu Provincial Academy of Traditional Chinese Medicine
Observed institutions:
Nanjing University of Chinese Medicine,
Jiangsu Provincial Academy of Traditional Chinese Medicine
ORCID:
0009-0007-8343-0856
Observed ORCID:
0009-0007-8343-0856
OpenAlex ID:
A5101908311
Magnetic Metal–Organic Framework-Based Nanoplatform with Platelet Membrane Coating as a Synergistic Programmed Cell Death Protein 1 Inhibitor against Hepatocellular Carcinoma
2023
·
Hong Guo
, Yuping Liu
, et al.
·
ACS Nano
·
58
Combination of oxymatrine (Om) and astragaloside IV (As) enhances the infiltration and function of TILs in triple-negative breast cancer (TNBC)
2023
·
Hong Wang
, Liangyin Wei
, et al.
·
International Immunopharmacology
·
23
Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor
2024
·
Hong Guo
, Xia Li
, et al.
·
Journal of Nanobiotechnology
·
22
Monocyte/Macrophage‐Mediated Transport of Dual‐Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein‐1 Inhibitor Against Microsatellite‐Stable Colorectal Cancer
2024
·
Xietao Ye
, Yuping Liu
, et al.
·
Advanced Science
·
21
Oxymatrine and astragaloside IV co-loaded liposomes: Scale-up purposes and their enhancement of anti-PD-1 efficacy against breast cancer
2025
·
Liangyin Wei
, Hong Wang
, et al.
·
Materials Today Bio
·
14
Preparation of in situ multifunctional traditional Chinese medicine thermosensitive microemulsion gel embolic agent for interventional therapy
2023
·
Xinmeng Shi
, Xietao Ye
, et al.
·
Journal of Drug Delivery Science and Technology
[Determination of di-alpha-phosphatidylcholine in the seeds of Astragalus chinensis L. by TLC-scanning].
1995
·
Y Xu
, L Wei
·
PubMed
Show more works
View as search
Works count:
9
Citation count:
138
H-index:
5
I10-index:
5
Year
Topic
Type